Merck & Co Inc (NYSE:MRK)

86.91
Delayed Data
As of Aug 21
 +1.26 / +1.47%
Today’s Change
66.10
Today|||52-Week Range
87.25
+13.74%
Year-to-Date

Today’s Trading

Previous close85.65
Today’s open86.29
Day’s range86.13 - 87.25
Volume6,188,981
Average volume (3 months)10,656,633
Market cap$217.4B
Data as of 6:30pm ET, 08/21/2019

Growth & Valuation

Earnings growth (last year)+165.32%
Earnings growth (this year)+12.84%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+6.17%
P/E ratio24.3
Price/Sales4.82
Price/Book8.25

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+1.04+1.17%
PFEPfizer+0.26+0.75%
AZNAstraZeneca+0.80+1.79%
LLYEli Lilly and Co+0.45+0.41%
Data as of 6:30pm ET, 08/21/2019

Financials

Next reporting dateOctober 29, 2019
EPS forecast (this quarter)$1.25
Annual revenue (last year)$42.4B
Annual profit (last year)$6.2B
Net profit margin14.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
CFO &
Executive Vice President-Global Services
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts